Skewed X chromosome inactivation and breast and ovarian cancer status: Evidence for X-linked modifiers of BRCA1

Journal of the National Cancer Institute

Volumn 100, Issue 21, 2008, Pages 1519-1529

  Lose, Felicity ^b,q   Duffy, David L ^b   Kay, Graham F ^b   Kedda, Mary A ^r   Spurdle, Amanda B ^b   Bowtell, D ^a   Chenevix Trench, G ^a,b   Green, A ^a,b   Webb, P ^a,b   DeFazio, A ^a,c   Gertig, D ^a,d   Traficante, N ^a,e   Moore, S ^a,f   Hung, J ^a,e   Fereday, S ^a,e   Harrap, K ^a,f   Sadkowsky, T ^a,f   Mellon, A ^a,p   Robertson, R ^a,p   Vanden Bergh, T ^a,g   Jones, Megan ^a,g   Maidens, J ^a,h   Nattress, K ^a,i   Chiew, Y E ^a,j   Stenlake, A ^a,j   Sullivan, H ^a,j   Alexander, B ^a,k   Ashover, P ^a,k   Brown, S ^a,k   Corrish, T ^a,k   Green, L ^a,k   Jackman, L ^a,k   Martin, K ^a,k   Ranieri, B ^a,k   White, J ^a,b   Jayde, V ^a,l   Bowes, L ^a,m   Mamers, P ^a,n   Schmidt, T ^a,o   Shirley, H ^a,o   Viduka, S ^a,o   Tran, Hoa ^a,o   Bilic, Sanela ^a,o   Glavinas, Lydia ^a,o   Stuart Harris, R ^a,e   Kirsten, F ^a,e   Rutovitz, J ^a,e   Clingan, P ^a,e   Glasgow, A ^a,e   Proietto, A ^a,e   Braye, S ^a,e   Otton, G ^a,e   Shannon, J ^a,e   Bonaventura, T ^a,e   Stewart, J ^a,e   Begbie, S ^a,e   Friedlander, M ^a,e   Bell, D ^a,e   Baron Hay, S ^a,e   Ferrier, A ^a,e   Gard, G ^a,e   Nevell, D ^a,e   Pavlakis, N ^a,e   Young, B ^a,e   Camaris, C ^a,e   Crouch, R ^a,e   Edwards, L ^a,e   Hacker, N ^a,e   Marsden, D ^a,e   Robertson, G ^a,e   Beale, P ^a,e   Beith, J ^a,e   Carter, J ^a,e   Dalrymple, C ^a,e   Hamilton, A ^a,e   Houghton, R ^a,e   Russell, P ^a,e   Links, M ^a,e   Grygiel, J ^a,e   Hill, J ^a,e   Brand, A ^a,e   Byth, K ^a,e   Jaworski, R ^a,e   Harnett, P ^a,e   Sharma, R ^a,e   Wain, G ^a,e   Purdie, D ^a,e   Whiteman, D ^a,e   Ward, B ^a,e   Papadimos, D ^a,e   Crandon, A ^a,e   Cummings, M ^a,e   Horwood, K ^a,e   Obermair, A ^a,e   Perrin, L ^a,e   Wyld, D ^a,e   Nicklin, J ^a,e   Davy, M ^a,e   Oehler, M ^a,e   Hall, C ^a,e   Dodd, T ^a,e   Healy, T ^a,e   Pittman, K ^a,e   Henderson, D ^a,e   Hyde, S ^a,a,e,e   Miller, J ^a,e   Pierdes, J ^a,e   Blomfield, P ^a,e   Challis, D ^a,e   McIntosh, R ^a,e   Parker, A ^a,e   Brown, B ^a,e   Rome, R ^a,e   Allen, D ^a,e   Grant, P ^a,e   Laurie, R ^a,e   Robbie, M ^a,e   Healy, D ^a,e   Jobling, T ^a,e   Manolitsas, T ^a,e   McNealage, J ^a,e   Rogers, P ^a,e   Susil, B ^a,e   Sumithran, E ^a,e   Simpson, I ^a,e   Haviv, I ^a,e   Phillips, K ^a,e   Rischin, D ^a,e   Fox, S ^a,e   Johnson, D ^a,e   Waring, P ^a,e   Loughrey, M ^a,e   O'Callaghan, N ^a,e   Murray, Bill ^a,e   Billson, V ^a,e   Pyman, J ^a,e   Neesham, D ^a,e   Quinn, M ^a,e   Underhill, C ^a,e   Bell, R ^a,e   Ng, L F ^a,e   Blum, R ^a,e   Ganju, V ^a,e   Hammond, I ^a,o   McCartney, A ^a,o   Leung, Y ^a,o   Buck, M ^a,o   Zeps, N ^a,o   more..

^a PETER MACCALLUM CANCER CENTRE   (Australia)

^b QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^c WESTMEAD HOSPITAL   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

^e PMCC ^*

^f QIMR

^g Royal Hospital for Women   (Australia)

^h ROYAL NORTH SHORE HOSPITAL   (Australia)

ⁱ ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^j WESTMEAD HOSPITAL   (Australia)

^k QIMR   (Australia)

^l ROYAL HOBART HOSPITAL   (Australia)

^m PMCC   (Australia)

ⁿ MONASH MEDICAL CENTRE   (Australia)

^o Western Australia Research Tissue Network WARTN   (Australia)

^p JOHN HUNTER HOSPITAL   (Australia)

^q UNIVERSITY OF QUEENSLAND   (Australia)

^r QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; BRCA2 ONCOGENE; BREAST CANCER; CANCER PATIENT; CONTROLLED STUDY; DNA METHYLATION; EXON; FAMILIAL CANCER; FEMALE; GENE AMPLIFICATION; GENE EXPRESSION; GENE FREQUENCY; GENE MUTATION; GENE SILENCING; HUMAN; MAJOR CLINICAL STUDY; MICROSATELLITE MARKER; NUCLEOTIDE SEQUENCE; ONCOGENE; ONSET AGE; OVARY CANCER; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECEPTOR GENE; X CHROMOSOME INACTIVATION;

EID: 55749112839     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djn345     Document Type: Article

References (51)

1. Gartler SM, Riggs AD. Mammalian X-chromosome inactivation. Annu Rev Genet. 1983;17:155-190.
2. Orstavik KH. Skewed X inactivation in healthy individuals and in different diseases. Acta Paediatr Suppl. 2006;95(451):24-29.
3. Buller RE, Sood AK, Lallas T, Buekers T, Skilling JS. Association between nonrandom X-chromosome inactivation and BRCA1 mutation in germline DNA of patients with ovarian cancer. J Natl Cancer Inst. 1999;91(4):339-346.
4. Sandovici I, Naumova AK, Leppert M, Linares Y, Sapienza C. A longitudinal study of X-inactivation ratio in human females. Hum Genet. 2004;115(5):387-392.
5. Knudsen GP, Pedersen J, Klingenberg O, Lygren I, Orstavik KH. Increased skewing of X chromosome inactivation with age in both blood and buccal cells. Cytogenet Genome Res. 2007;116(1-2):24-28.
6. Vickers MA, McLeod E, Spector TD, Wilson IJ. Assessment of mechanism of acquired skewed X inactivation by analysis of twins. Blood. 2001;97(5):1274-1281.
7. Kristiansen M, Knudsen GP, Bathum L, et al. Twin study of genetic and aging effects on X chromosome inactivation. Eur J Hum Genet. 2005;13(5):599-606.
8. Christensen K, Kristiansen M, Hagen-Larsen H, et al. X-linked genetic factors regulate hematopoietic stem-cell kinetics in females. Blood. 2000;95(7):2449-2451.
9. Naumova AK, Olien L, Bird LM, et al. Genetic mapping of X-linked loci involved in skewing of X chromosome inactivation in the human. Eur J Hum Genet. 1998;6(6):552-562.
10. Cau M, Addis M, Congiu R, et al. A locus for familial skewed X chromosome inactivation maps to chromosome Xq25 in a family with a female manifesting Lowe syndrome. J Hum Genet. 2006;51(11):1030-1036.
11. Bicocchi MP, Migeon BR, Pasino M, et al. Familial nonrandom inactivation linked to the X inactivation centre in heterozygotes manifesting haemophilia A. Eur J Hum Genet. 2005;13(5):635-640.
12. Plenge RM, Hendrich BD, Schwartz C, et al. A promoter mutation in the XIST gene in two unrelated families with skewed X-chromosome inactivation. Nat Genet. 1997;17(3):353-356.
13. Ferraris AM, Forni GL, Mangerini R, Gaetani GF. Nonrandom X-chromosome inactivation in hemopoietic cells from carriers of dyskeratosis congenita. Am J Hum Genet. 1997;61(2):458-461.
14. Holden ST, Cox JJ, Kesterton I, Thomas NS, Carr C, Woods CG. Fanconi anaemia complementation group B presenting as X linked VACTERL with hydrocephalus syndrome. J Med Genet. 2006;43(9):750-754.
15. Meetei AR, Levitus M, Xue Y, et al. X-linked inheritance of Fanconi anemia complementation group B. Nat Genet. 2004;36(11):1219-1224.
16. Parolini O, Ressmann G, Haas OA, et al. X-linked Wiskott-Aldrich syndrome in a girl. N Engl J Med. 1998;338(5):291-295.
17. Maier EM, Kammerer S, Muntau AC, Wichers M, Braun A, Roscher AA. Symptoms in carriers of adrenoleukodystrophy relate to skewed X inactivation. Ann Neurol. 2002;52(5):683-688.
18. Amos-Landgraf JM, Cottle A, Plenge RM, et al. X chromosome-inactivation patterns of 1,005 phenotypically unaffected females. Am J Hum Genet. 2006;79(3):493-499.
19. Kristiansen M, Knudsen GP, Maguire P, et al. High incidence of skewed X chromosome inactivation in young patients with familial non-BRCA1/BRCA2 breast cancer. J Med Genet. 2005;42:877-880.
20. Busque L, Mio R, Mattioli J, et al. Nonrandom X-inactivation patterns in normal females: lyonization ratios vary with age. Blood. 1996;88(1):59-65.
21. Kristiansen M, Langerod A, Knudsen GP, Weber BL, Borresen-Dale AL, Orstavik KH. High frequency of skewed X inactivation in young breast cancer patients. J Med Genet. 2002;39(1):30-33.
22. Jazaeri AA, Chandramouli GV, Aprelikova O, et al. BRCA1-mediated repression of select X chromosome genes. J Transl Med. 2004;2(1):32.
23. Richardson AL, Wang ZC, De Nicolo A, et al. X chromosomal abnormalities in basal-like human breast cancer. Cancer Cell. 2006;9(2):121-132.
24. Ganesan S, Silver DP, Greenberg RA, et al. BRCA1 supports XIST RNA concentration on the inactive X chromosome. Cell. 2002;111(3):393-405.
25. Silver DP, Dimitrov SD, Feunteun J, et al. Further evidence for BRCA1 communication with the inactive X chromosome. Cell. 2007;128(5):991-1002.
26. Pageau GJ, Hall LL, Lawrence JB. BRCA1 does not paint the inactive X to localize XIST RNA but may contribute to broad changes in cancer that impact XIST and Xi heterochromatin. J Cell Biochem. 2006;100(4):835-850.
27. Sirchia SM, Ramoscelli L, Grati FR, et al. Loss of the inactive X chromosome and replication of the active X in BRCA1-defective and wild-type breast cancer cells. Cancer Res. 2005;65(6):2139-2146.
28. Xiao C, Sharp JA, Kawahara M, et al. The XIST noncoding RNA functions independently of BRCA1 in X inactivation. Cell. 2007;128(5):977-989.
29. Vincent-Salomon A, Ganem-Elbaz C, Manie E, et al. X Inactive-specific transcript RNA coating and genetic instability of the X chromosome in BRCA1 breast tumors. Cancer Res. 2007;67(11):5134-5140.
30. Struewing JP, Pineda MA, Sherman ME, et al. Skewed X chromosome inactivation and early-onset breast cancer. J Med Genet. 2006;43(1):48-53.
31. Helbling-Leclerc A, Lenoir GM, Feunteun J. Heterozygote BRCA1 status and skewed chromosome X inactivation. Fam Cancer. 2006;6(1):153-157.
32. Kubota T, Nonoyama S, Tonoki H, et al. A new assay for the analysis of X-chromosome inactivation based on methylation-specific PCR. Hum Genet. 1999;104(1):49-55.
33. Marsh A, Healey S, Lewis A, et al. Mutation analysis of five candidate genes in familial breast cancer. Breast Cancer Res Treat. 2006;105(3):337-389.
34. Jordan SJ, Green AC, Whiteman DC, Webb PM. Risk factors for benign serous and mucinous epithelial ovarian tumors. Obstet Gynecol. 2007;109(3):647-654.
35. Mann GJ, Thorne H, Balleine RL, et al. Analysis of cancer risk and BRCA1 and BRCA2 mutation prevalence in the kConFab familial breast cancer resource. Breast Cancer Res. 2006;8(1):R12.
36. Sleddens HF, Oostra BA, Brinkmann AO, Trapman J. Trinucleotide repeat polymorphism in the androgen receptor gene (AR). Nucleic Acids Res. 1992;20(6):1427.
37. Allen RC, Zoghbi HY, Moseley AB, Rosenblatt HM, Belmont JW. Methylation of HpaII and HhaI sites near the polymorphic CAG repeat in the human androgen-receptor gene correlates with X chromosome inactivation. Am J Hum Genet. 1992;51(6):1229-1239.
38. Rozen S, Skaletsky HJ. Primer3 on the WWW for general users and for biologist programmers. In: Krawetz S, Misener S, eds. Bioinformatics Methods and Protocols: Methods in Molecular Biology. Totowa, NJ:Humana Press; 2000:365-386.
39. Flanagan JM, Healey S, Young J, et al. Mapping of a candidate colorectal cancer tumor-suppressor gene to a 900-kilobase region on the short arm of chromosome 8. Genes Chromosomes Cancer. 2004;40(3):247-260.
40. Huber PJ. The behaviour of maximum likelihood estimates under non-standard conditions. In: Le Cam LM, Neyman J, eds. Fifth Berkeley Symposium in Mathematical Statistics and Probability. Berkeley, CA: University of California Press; 1967:221-233.
41. n polymorphisms and breast cancer risk in a population-based case-control study of young women. Cancer Epidemiol Biomarkers Prev. 2003;12(2):127-135.
42. Modugno F. Ovarian cancer and polymorphisms in the androgen and progesterone receptor genes: a HuGE review. Am J Epidemiol. 2004;159(4):319-335.
43. Carey LA, Perou CM, Livasy CA, et al. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA. 2006;295(21):2492- 2502.
44. Sorlie T, Tibshirani R, Parker J, et al. Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci USA. 2003;100(14):8418-8423.
45. Marahrens Y, Loring J, Jaenisch R. Role of the Xist gene in X chromosome choosing. Cell. 1998;92(5):657-664.
46. Cohen DE, Davidow LS, Erwin JA, Xu N, Warshawsky D, Lee JT. The DXPas34 repeat regulates random and imprinted X inactivation. Dev Cell. 2007;12(1):57-71.
47. Jazaeri AA, Yee CJ, Sotiriou C, Brantley KR, Boyd J, Liu ET. Gene expression profiles of BRCA1-linked, BRCA2-linked, and sporadic ovarian cancers. J Natl Cancer Inst. 2002;94(13):990-1000.
48. Jasin M. Homologous repair of DNA damage and tumorigenesis: the BRCA connection. Oncogene. 2002;21(58):8981-8993.
49. Holden ST, Cox JJ, Kesterton I, Thomas NS, Carr C, Woods CG. Fanconi anaemia complementation group B presenting as X-linked VACTERL with hydrocephalus syndrome. J Med Genet. 2006;43(9):750-754.
50. Mathew CG. Fanconi anaemia genes and susceptibility to cancer. Oncogene. 2006;25(43):5875-5884.
51. Zuo T, Wang L, Morrison C, et al. FOXP3 is an X-linked breast cancer suppressor gene and an important repressor of the HER-2/ErbB2 oncogene. Cell. 2007;129(7):1275-1286.